Category: Clinical Chemistry
Singapore Clinical Chemistry
-
2024 Singapore Clinical Chemistry Market Supplier Shares - Competitive Analysis of Leading and Emerging Market Players
... and reagents, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. The companies profiled in the report include: Abbott Agilent Technologies Beckman Coulter/Danaher bioMerieux Bio-Rad DiaSorin ... Read More
-
2024-2029 Singapore Clinical Chemistry and Immunodiagnostic Analyzers and Reagents - 2024 Supplier Shares, 2024-2029 Volume and Sales Segment Forecasts for 100 Tests - Abused Drugs, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Assays - High-Growth Opportunities for Suppliers, Competitive Analysis and Growth Strategies, Latest Technologies and Instrumentation Pipeline
... Opportunities for Suppliers, Competitive Analysis and Growth Strategies, Latest Technologies and Instrumentation Pipeline This new report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in ... Read More
-
2024-2029 Singapore Diagnostics Market for 500 Tests: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for 500 Blood Banking, Cancer Diagnostic, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, and TDM Tests, Strategic Profiles of Leading Competitors
... Diseases, Molecular Diagnostics, and TDM Tests, Strategic Profiles of Leading Competitors This new report from LeadingMarketResearch.com provides granular analysis of the diagnostic testing market, including 2024 supplier shares, strategies, as well as 2024-2029 volume and ... Read More
-
ASEAN Medical Diagnostics Market (Singapore, Malaysia, Indonesia, Thailand & Vietnam): Insights & Forecast with Potential Impact of COVID-19 (2024-2028)
... a CAGR of 12.60%, over the period 2024-2028. The factors such as increasing geriatric population, escalating stress levels, hike in healthcare expenditure and expanding urbanization and surging prevalence of western type diseases in South East ... Read More
-
2024 What's Next for Singapore Diagnostics Market? - Supplier Shares and Strategies, 2023-2028 Volume and Sales Forecasts for 500 Tests - Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM
... Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM This new report from LeadingMarketResearch.com provides granular analysis of the diagnostic testing market, including 2023 supplier shares, strategies, as well as 2023-2028 volume and sales forecasts for 500 ... Read More
-
2024 Singapore Clinical Chemistry and Immunodiagnostics Market - 2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein and TDM Tests
... provides information and analysis not available from any other published source . Clinical Chemistry Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, Apolipoprotein A-1, Apolipoprotein B, AST/SGOT, Beta-Hydroxybutyrate, Bilirubin (Direct), Bilirubin (Total), BNP, BUN (Blood Urea Nitrogen), ... Read More
-
In Vitro Diagnostics (IVD) in Malaysia, Singapore and Indonesia, 2022
... Southeast Asia has been identified as one of the key regions in APAC region offering significant opportunities for IVD companies. This report focuses on three IVD markets in Southeast Asia: Malaysia, Indonesia, and Singapore. These ... Read More
Research Assistance
